354 related articles for article (PubMed ID: 35950602)
1. A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice.
Zheng S; Yang W; Yao D; Tang S; Hou J; Chang X
Ann Med; 2022 Dec; 54(1):2233-2245. PubMed ID: 35950602
[TBL] [Abstract][Full Text] [Related]
2. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
[TBL] [Abstract][Full Text] [Related]
3. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.
Syn WK; Oo YH; Pereira TA; Karaca GF; Jung Y; Omenetti A; Witek RP; Choi SS; Guy CD; Fearing CM; Teaberry V; Pereira FE; Adams DH; Diehl AM
Hepatology; 2010 Jun; 51(6):1998-2007. PubMed ID: 20512988
[TBL] [Abstract][Full Text] [Related]
5. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.
Syn WK; Agboola KM; Swiderska M; Michelotti GA; Liaskou E; Pang H; Xie G; Philips G; Chan IS; Karaca GF; Pereira Tde A; Chen Y; Mi Z; Kuo PC; Choi SS; Guy CD; Abdelmalek MF; Diehl AM
Gut; 2012 Sep; 61(9):1323-9. PubMed ID: 22427237
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
[TBL] [Abstract][Full Text] [Related]
7. Indole supplementation ameliorates MCD-induced NASH in mice.
Zhu B; Li H; Lu B; Guo X; Wu C; Wang F; Li Q; Xie L; Glaser S; Francis H; Alpini G; Wu C
J Nutr Biochem; 2022 Sep; 107():109041. PubMed ID: 35568098
[TBL] [Abstract][Full Text] [Related]
8. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.
Maricic I; Marrero I; Eguchi A; Nakamura R; Johnson CD; Dasgupta S; Hernandez CD; Nguyen PS; Swafford AD; Knight R; Feldstein AE; Loomba R; Kumar V
J Immunol; 2018 Nov; 201(10):3017-3035. PubMed ID: 30322964
[TBL] [Abstract][Full Text] [Related]
9. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice.
Motiño O; Agra N; Brea Contreras R; Domínguez-Moreno M; García-Monzón C; Vargas-Castrillón J; Carnovale CE; Boscá L; Casado M; Mayoral R; Valdecantos MP; Valverde ÁM; Francés DE; Martín-Sanz P
Biochim Biophys Acta; 2016 Sep; 1862(9):1710-23. PubMed ID: 27321932
[TBL] [Abstract][Full Text] [Related]
11. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
12. Hepatic NK cells attenuate fibrosis progression of non-alcoholic steatohepatitis in dependent of CXCL10-mediated recruitment.
Fan Y; Zhang W; Wei H; Sun R; Tian Z; Chen Y
Liver Int; 2020 Mar; 40(3):598-608. PubMed ID: 31758647
[TBL] [Abstract][Full Text] [Related]
13. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
Itagaki H; Shimizu K; Morikawa S; Ogawa K; Ezaki T
Int J Clin Exp Pathol; 2013; 6(12):2683-96. PubMed ID: 24294355
[TBL] [Abstract][Full Text] [Related]
14. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis.
Kimura K; Inaba Y; Watanabe H; Matsukawa T; Matsumoto M; Inoue H
J Diabetes Investig; 2019 May; 10(3):659-666. PubMed ID: 30369082
[TBL] [Abstract][Full Text] [Related]
16. Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis.
González-Rodríguez Á; Valdecantos MP; Rada P; Addante A; Barahona I; Rey E; Pardo V; Ruiz L; Laiglesia LM; Moreno-Aliaga MJ; García-Monzón C; Sánchez A; Valverde ÁM
Mol Metab; 2018 Jan; 7():132-146. PubMed ID: 29126873
[TBL] [Abstract][Full Text] [Related]
17. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.
Dixon LJ; Berk M; Thapaliya S; Papouchado BG; Feldstein AE
Lab Invest; 2012 May; 92(5):713-23. PubMed ID: 22411067
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
[TBL] [Abstract][Full Text] [Related]
19. Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.
Kim TH; Banini BA; Asumda FZ; Campbell NA; Hu C; Moser CD; Shire AM; Han S; Ma C; Krishnan A; Mounajjed T; White TA; Gores GJ; LeBrasseur NK; Charlton MR; Roberts LR
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G333-G344. PubMed ID: 32683952
[TBL] [Abstract][Full Text] [Related]
20. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
